Baird Financial Group, Inc. Green Light Biosciences Holdings, Pbc Transaction History

Baird Financial Group, Inc.

  • $47.3 Billion
  • Q1 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
SELL
$0.34 - $1.19 $200,052 - $700,184
-588,390 Reduced 37.88%
965,080 $414,000
Q3 2022

Nov 14, 2022
BUY
$0.42 - $3.92 $1.2 Million - $11.2 Million
2,856,695 New
2,856,695 $6.63 Million

Others Institutions Holding GRNA

# of Institutions
1
Shares Held
51.5K
Call Options Held
0
Put Options Held
0
View Full List

About GreenLight Biosciences Holdings, PBC

GRNA Quotes by TradingView
  • Ticker GRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 151,460,000
  • Description
  • GreenLight Biosciences Holdings, a biotechnology company, manufactures and sells ribonucleic acid (RNA) products for human health and agriculture applications. Its products for human health include mRNA vaccines and therapeutics; and agricultural RNA products to protect honeybees and crops. The company was founded in 2008 and is headquartered in...
More about GRNA
Track This Portfolio

Track Baird Financial Group, Inc. Portfolio

Follow Baird Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baird Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Baird Financial Group, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email